Evidence map›Paper›PMID 40043709›Full record

ArticleCell genomics2025

A highland-adaptation variant near MCUR1 reduces its transcription and attenuates erythrogenesis in Tibetans.

Jie Ping, Xinyi Liu, Yiming Lu, Cheng Quan, Pengcheng Fan, Hao Lu, Qi Li, Cuiling Wang, Zheng Zhang, Mengyu Liu and 35 more

Abstract read
In one paragraph

Article in Cell genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors.

Jie PingState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Xinyi LiuState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Yiming LuState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Cheng QuanState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Pengcheng FanPharmacy Department, General Hospital of Lanzhou, Lanzhou City 730050, P.R. China; State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, P.R. China.
Hao LuState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Qi LiState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Cuiling WangState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Zheng ZhangState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Mengyu LiuState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Shunqi ChenState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Lingle ChangMedical College of Guizhou University, Guiyang City 550025, P.R. China.
Yuqing JiangCollaborative Innovation Center for Personalized Cancer Medicine, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City 211166, P.R. China.
Qilin HuangCollaborative Innovation Center for Personalized Cancer Medicine, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City 211166, P.R. China.
Jie LiuResearch Center for High-Altitude Medicine, Qinghai University Medical School, Xining City 810001, P.R. China; Qinghai Provincial People's Hospital, Xining City 810001, P.R. China.
Tana WurenResearch Center for High-Altitude Medicine, Qinghai University Medical School, Xining City 810001, P.R. China.
Huifang LiuResearch Center for High-Altitude Medicine, Qinghai University Medical School, Xining City 810001, P.R. China.
Ying HaoCollege of Life Sciences, Beijing University of Chinese Medicine, Beijing 102488, P.R. China.
Longli KangKey Laboratory for Molecular Genetic Mechanisms and Intervention Research on High-Altitude Disease of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang City 712082, P.R. China; Key Laboratory of High-Altitude Environment and Genes Related to Diseases of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang City 712082, P.R. China.
Guanjun LiuHenan Provincial People's Hospital, Zhengzhou City 450000, P.R. China; Affiliated Cancer Hospital of Guangxi Medical University, Nanning City 530021, P.R. China.
Hui LuState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Xiaojun WeiState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Yuting WangState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Yuanfeng LiState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Hao GuoNo. 945 Hospital of Joint Logistic Support Force of Chinese PLA, Ya'an City 625000, P.R. China.
Yongquan CuiNo. 945 Hospital of Joint Logistic Support Force of Chinese PLA, Ya'an City 625000, P.R. China.
Haoxiang ZhangNo. 954 Hospital of Joint Logistic Support Force of Chinese PLA, Shannan City 856000, P.R. China.
Yang ZhangMedical Center for Human Reproduction, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, P.R. China.
Yujia ZhaiCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, P.R. China.
Yaoxi HeState Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming City 650223, P.R. China.
Wangshan ZhengState Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming City 650223, P.R. China.
Xuebin QiState Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming 650000, China; Fukang Obstetrics, Gynecology and Children Branch Hospital, Tibetan Fukang Hospital, Lhasa 850000, China.
OuzhuluobuFukang Obstetrics, Gynecology and Children Branch Hospital, Tibetan Fukang Hospital, Lhasa 850000, China.
Huiping MaPharmacy Department, General Hospital of Lanzhou, Lanzhou City 730050, P.R. China.
Linpeng YangPharmacy Department, General Hospital of Lanzhou, Lanzhou City 730050, P.R. China.
Xin WangPharmacy Department, General Hospital of Lanzhou, Lanzhou City 730050, P.R. China.
Wanjun JinPharmacy Department, General Hospital of Lanzhou, Lanzhou City 730050, P.R. China.
Ying CuiAffiliated Cancer Hospital of Guangxi Medical University, Nanning City 530021, P.R. China.
Rili GeResearch Center for High-Altitude Medicine, Qinghai University Medical School, Xining City 810001, P.R. China.
Shizheng WuResearch Center for High-Altitude Medicine, Qinghai University Medical School, Xining City 810001, P.R. China; Qinghai Provincial People's Hospital, Xining City 810001, P.R. China.
Yuan WeiCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, P.R. China.
Bing SuState Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming City 650223, P.R. China.
Fuchu HeState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, P.R. China.
Hongxing ZhangState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, P.R. China. Electronic address: zhanghx08@126.com.
Gangqiao ZhouState Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China; Medical College of Guizhou University, Guiyang City 550025, P.R. China; Collaborative Innovation Center for Personalized Cancer Medicine, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing City 211166, P.R. China. Electronic address: zhougq114@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To identify genomic regions subject to positive selection that might contain genes involved in high-altitude adaptation (HAA), we performed a genome-wide scan by whole-genome sequencing of Tibetan highlanders and Han lowlanders. We revealed a collection of candidate genes located in 30 genomic loci under positive selection. Among them, MCUR1 at 6p23 was a novel pronounced candidate. By single-cell RNA sequencing and comprehensive functional studies, we demonstrated that MCUR1 depletion leads to impairment of erythropoiesis under hypoxia and normoxia. Mechanistically, MCUR1 knockdown reduced mitochondrial Ca

Indexed as

Adaptation, PhysiologicalErythropoiesisAltitudeCalciumEast Asian PeopleFemaleHumansMaleMitochondriaPolymorphism, Single NucleotideQuantitative Trait LociTibetTranscription, GeneticCalciumerythropoiesisgene regulationhigh-altitude adaptationhuman evolutionhypoxiaMCUR1polymorphismsingle-cell RNA sequencingstanding variantwhole-genome sequencing

Identifiers

PMID40043709
PMCPMC11960549

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.